News
AARDEX Group and AdhereTech Partnership Boosts Medication Adherence with Software, Data Analytics and Smart Pill Bottle
Belgium-based AARDEX Group, the world leader in medication adherence solutions, announced a strategic partnership with AdhereTech, an innovative company that improves the patient experience with real-time technology and Smart devices for optimal medication benefits. The collaboration will link AARDEX’s...
News
Genezen Strengthens Leadership with New Board Appointments
Following major growth, Genezen Laboratories Inc, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has announced the appointment of three board members: Iain Baird, Diana Caldwell and Tedd Green.
The expansion of the team comes as Genezen...
News
Singapore-UK Team To Develop a Novel Device to Reduce Chemotherapy Side-Effects
A team of clinicians and scientists from the National University Cancer Institute, Singapore (NCIS) at the National University Hospital (NUH) and the N.1 Institute for Health at the National University of Singapore (NUS) has partnered Paxman Coolers Ltd (UK)...
News
Ashfield Advisory takes strategic step forward with two new additions to senior leadership team
Ashfield Advisory, an ecosystem of healthcare advisory and consulting businesses, part of UDG Healthcare plc., has announced two senior leadership appointments.
Mary-Kate McGarry joins in the new position of Vice President of Strategy and Emer Jameson, steps into the role...
News
Vibalogics invests an additional $50 million to further expand cGMP manufacturing capacity for viral vectors
Vibalogics, a global contract development and manufacturing organization (CDMO), has today announced that it has initiated the first stage of a planned $50 million dollar investment at its Cuxhaven, Germany facility, expanding early-to-late phase clinical virotherapy manufacturing capacity.
The investment...
News
MaxiVision Eye Hospitals launches Mucormycosis (Black Fungus) Early Detection Center
MaxiVision Eye Hospitals group, the pioneers in the industry of eye care medical services have launched “Mucormycosis (Black Fungus) Early Detection Center” at its Somajiguda Branch in Hyderabad to identify the virulent fungal infection in its initial stage preventing...
Drug Research
mCureX and Samyang sign MoU for mRNA vaccine development
OliX Pharmaceuticals’ subsidiary mCureX has entered a memorandum of understanding (MoU) with Samyang Holdings to develop a messenger ribonucleic acid (mRNA) vaccine for Covid-19.
The companies are co-developing a vaccine that could potentially target Covid-19 viral variants.
According to the deal,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read